PT2448968T - ANTICORPOS SELETIVOS PARA PROTOFIBRILAS/OLIGÓMEROS DE ß- AMILOIDE TRUNCADA EM N-TERMINAL - Google Patents
ANTICORPOS SELETIVOS PARA PROTOFIBRILAS/OLIGÓMEROS DE ß- AMILOIDE TRUNCADA EM N-TERMINALInfo
- Publication number
- PT2448968T PT2448968T PT107397010T PT10739701T PT2448968T PT 2448968 T PT2448968 T PT 2448968T PT 107397010 T PT107397010 T PT 107397010T PT 10739701 T PT10739701 T PT 10739701T PT 2448968 T PT2448968 T PT 2448968T
- Authority
- PT
- Portugal
- Prior art keywords
- alzheimer
- oligomers
- therapeutic
- disease
- diagnostic methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22110509P | 2009-06-29 | 2009-06-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2448968T true PT2448968T (pt) | 2021-04-30 |
Family
ID=42832352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT107397010T PT2448968T (pt) | 2009-06-29 | 2010-06-29 | ANTICORPOS SELETIVOS PARA PROTOFIBRILAS/OLIGÓMEROS DE ß- AMILOIDE TRUNCADA EM N-TERMINAL |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20120100129A1 (pt) |
| EP (2) | EP3892633A1 (pt) |
| JP (3) | JP2012532094A (pt) |
| AU (1) | AU2010267640B2 (pt) |
| CA (1) | CA2765602C (pt) |
| CY (1) | CY1124034T1 (pt) |
| DK (1) | DK2448968T3 (pt) |
| ES (1) | ES2864049T3 (pt) |
| HR (1) | HRP20210611T1 (pt) |
| HU (1) | HUE053949T2 (pt) |
| LT (1) | LT2448968T (pt) |
| PL (1) | PL2448968T3 (pt) |
| PT (1) | PT2448968T (pt) |
| SI (1) | SI2448968T1 (pt) |
| SM (1) | SMT202100237T1 (pt) |
| WO (1) | WO2011001366A1 (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0401601D0 (sv) | 2004-06-21 | 2004-06-21 | Bioarctic Neuroscience Ab | Protofibril specific antibodies and uses thereof |
| PL2004688T5 (pl) | 2006-03-23 | 2014-09-30 | Bioarctic Neuroscience Ab | Ulepszone przeciwciała wobec protofibryli oraz ich zastosowania |
| CN110655573B (zh) | 2010-02-26 | 2023-07-18 | 生命北极神经科学公司 | 原细纤维结合抗体及其治疗和诊断帕金森氏症、路易体痴呆和其他α-共核蛋白病的应用 |
| WO2012123562A1 (en) * | 2011-03-16 | 2012-09-20 | Probiodrug Ag | Diagnostic antibody assay |
| JO3537B1 (ar) | 2014-07-10 | 2020-07-05 | Bioarctic Neuroscience Ab | أجسام مضادة لييفية أولية لاميلويد بيتا الببتيد ab المحسنة |
| EP3325506A1 (en) | 2015-07-21 | 2018-05-30 | BioArctic AB | Method for treatment of traumatic brain injury targeting aggregated peptides |
| CN109476728A (zh) | 2016-07-14 | 2019-03-15 | 生命北极公司 | 脑部递送蛋白 |
| US12227567B2 (en) | 2017-07-25 | 2025-02-18 | Truebinding, Inc. | Treating cancer by blocking the interaction of TIM-3 and its ligand |
| CN118924896A (zh) | 2018-07-24 | 2024-11-12 | 卫材R&D管理有限公司 | 阿尔茨海默病的治疗及预防方法 |
| CN116063520A (zh) | 2019-01-30 | 2023-05-05 | 真和制药有限公司 | 抗gal3抗体及其用途 |
| JPWO2021006212A1 (pt) * | 2019-07-08 | 2021-01-14 | ||
| WO2021055670A1 (en) | 2019-09-20 | 2021-03-25 | Avx Corporation | Somatic cell-based electrical biosensor |
| CN116157151A (zh) | 2020-05-26 | 2023-05-23 | 真和制药有限公司 | 通过阻断半乳凝素-3治疗炎性疾病的方法 |
| MA60122B1 (fr) | 2020-06-26 | 2025-07-31 | Bioarctic Ab | Anticorps se liant à la protofibrille d'alpha-synucléine |
| TW202317192A (zh) | 2021-07-09 | 2023-05-01 | 日商衛材R&D企管股份有限公司 | 用於阿茲海默氏症治療的生物標記物 |
| MX2024002567A (es) | 2021-08-30 | 2024-03-20 | Eisai R&D Man Co Ltd | Formulaciones subcutaneas de anticuerpo anti protofibrillas de beta-amiloide (abeta) y metodos de uso de las mismas. |
| US20250377367A1 (en) | 2022-02-02 | 2025-12-11 | Eisai R&D Management Co., Ltd. | Methods of treatment using p-tau181 level |
| WO2024133925A1 (en) | 2022-12-22 | 2024-06-27 | Bioarctic Ab | Antibody which binds to abetape3 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5604102A (en) | 1992-04-15 | 1997-02-18 | Athena Neurosciences, Inc. | Methods of screening for β-amyloid peptide production inhibitors |
| JP4796725B2 (ja) * | 1999-08-04 | 2011-10-19 | ユニバーシティ オブ サザン カリフォルニア | アミロイドβタンパク質（球状アセンブリー及びその使用） |
| JP5362164B2 (ja) * | 2000-07-07 | 2013-12-11 | バイオアークティック ニューロサイエンス アーベー | アルツハイマー病の予防及び治療 |
| US7122374B1 (en) * | 2002-04-09 | 2006-10-17 | Takaomi Saido | Amyloid beta-protein 3(pE)-42 antibodies and uses thereof |
| CA2487528A1 (en) * | 2002-07-24 | 2004-02-12 | Innogenetics N.V. | Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation |
| WO2005100402A1 (en) * | 2004-04-13 | 2005-10-27 | F.Hoffmann-La Roche Ag | Anti-p-selectin antibodies |
| GB0413726D0 (en) * | 2004-06-18 | 2004-07-21 | Lauras As | Compounds |
| SE0401601D0 (sv) * | 2004-06-21 | 2004-06-21 | Bioarctic Neuroscience Ab | Protofibril specific antibodies and uses thereof |
| SG190665A1 (en) * | 2004-07-30 | 2013-06-28 | Rinat Neuroscience Corp | Antibodies directed against amyloid-beta peptide and methods using same |
| PL2004688T5 (pl) * | 2006-03-23 | 2014-09-30 | Bioarctic Neuroscience Ab | Ulepszone przeciwciała wobec protofibryli oraz ich zastosowania |
| BRPI0819312A2 (pt) * | 2007-11-16 | 2020-09-15 | The Rockefeller University | específico anticorpo para a forma protofibril de proteínas amilóide beta |
| LT2282758T (lt) * | 2008-04-29 | 2019-03-12 | Bioarctic Ab | Antikūnai ir vakcinos, skirti su alfa sinukleinu susijusių sutrikimų gydymo ir diagnostiniams metodams |
-
2010
- 2010-06-29 JP JP2012516964A patent/JP2012532094A/ja not_active Withdrawn
- 2010-06-29 EP EP21153326.0A patent/EP3892633A1/en active Pending
- 2010-06-29 HR HRP20210611TT patent/HRP20210611T1/hr unknown
- 2010-06-29 AU AU2010267640A patent/AU2010267640B2/en active Active
- 2010-06-29 SI SI201032068T patent/SI2448968T1/sl unknown
- 2010-06-29 CA CA2765602A patent/CA2765602C/en active Active
- 2010-06-29 WO PCT/IB2010/052947 patent/WO2011001366A1/en not_active Ceased
- 2010-06-29 PT PT107397010T patent/PT2448968T/pt unknown
- 2010-06-29 DK DK10739701.0T patent/DK2448968T3/da active
- 2010-06-29 LT LTEP10739701.0T patent/LT2448968T/lt unknown
- 2010-06-29 SM SM20210237T patent/SMT202100237T1/it unknown
- 2010-06-29 HU HUE10739701A patent/HUE053949T2/hu unknown
- 2010-06-29 US US13/379,523 patent/US20120100129A1/en not_active Abandoned
- 2010-06-29 PL PL10739701T patent/PL2448968T3/pl unknown
- 2010-06-29 ES ES10739701T patent/ES2864049T3/es active Active
- 2010-06-29 EP EP10739701.0A patent/EP2448968B1/en active Active
-
2017
- 2017-04-19 JP JP2017083057A patent/JP6884025B2/ja active Active
-
2019
- 2019-08-01 JP JP2019142344A patent/JP2019218362A/ja active Pending
-
2021
- 2021-04-27 CY CY20211100361T patent/CY1124034T1/el unknown
-
2022
- 2022-12-15 US US18/066,998 patent/US20230295283A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2765602C (en) | 2021-05-25 |
| SMT202100237T1 (it) | 2021-05-07 |
| JP6884025B2 (ja) | 2021-06-09 |
| JP2017197531A (ja) | 2017-11-02 |
| HUE053949T2 (hu) | 2021-08-30 |
| AU2010267640B2 (en) | 2015-03-05 |
| US20230295283A1 (en) | 2023-09-21 |
| US20120100129A1 (en) | 2012-04-26 |
| WO2011001366A1 (en) | 2011-01-06 |
| LT2448968T (lt) | 2021-05-10 |
| CY1124034T1 (el) | 2022-05-27 |
| JP2019218362A (ja) | 2019-12-26 |
| HRP20210611T1 (hr) | 2021-05-28 |
| EP2448968A1 (en) | 2012-05-09 |
| EP3892633A1 (en) | 2021-10-13 |
| DK2448968T3 (da) | 2021-04-12 |
| SI2448968T1 (sl) | 2021-07-30 |
| PL2448968T3 (pl) | 2021-09-13 |
| JP2012532094A (ja) | 2012-12-13 |
| CA2765602A1 (en) | 2011-01-06 |
| EP2448968B1 (en) | 2021-01-27 |
| AU2010267640A1 (en) | 2012-01-19 |
| ES2864049T3 (es) | 2021-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2448968T (pt) | ANTICORPOS SELETIVOS PARA PROTOFIBRILAS/OLIGÓMEROS DE ß- AMILOIDE TRUNCADA EM N-TERMINAL | |
| HUE041223T2 (hu) | Antitestek és vakcinák alfa-szinukleinnel összefüggõ betegségek terápiás és diagnosztikai eljárásaiban történõ alkalmazásra | |
| IL215842A0 (en) | Intrauterine system for use in medical treatment | |
| PL2393399T3 (pl) | Materac przeznaczony do użytku w domach opieki i szpitalach | |
| LT2539366T (lt) | Protofibriles surišantys antikūnai ir jų panaudojimas parkinsono ligos, demencijos su levi kūneliais ir kitų alfa-sinukleinopatijų terapiniuose ir diagnostiniuose būduose | |
| LT2758433T (lt) | Alzheimerio ligos tau-sąlygojamos patologijos terapija ir diagnostika baltymų pagrindu | |
| ZA201107085B (en) | Indolizine derivative and use thereof for medical purposes | |
| IL220684A (en) | Anaphylactic therapy for Alzheimer's and the aging brain | |
| EP2386239A4 (en) | IN VIVO IMAGING SYSTEM OF THE SUBJECT AND IN VIVO INTRODUCTION DEVICE IN THE FIELD | |
| EP2182978A4 (en) | TISSUE KALLIKREIN FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID PROTEIN | |
| PT2405928T (pt) | Métodos de tratamento e de diagnóstico para patologias de hipersensibilidade | |
| PL2410922T3 (pl) | Urządzenie do przeprowadzania procedur diagnostycznych i/lub terapeutycznych | |
| GB201121597D0 (en) | Polyurethane oligomers for use in restorative dentistry | |
| GB0918392D0 (en) | Diagnostic and therapeutic methods | |
| ZA201106056B (en) | Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention | |
| PT2470066E (pt) | Método não invasivo para avaliação da perfusão de tecidos num doente | |
| PL2565184T3 (pl) | Środek terapeutyczny i środek zapobiegawczy przeciwko chorobie alzheimera | |
| GB0912665D0 (en) | Force-transmitting element for use in medical catheters | |
| GB0905970D0 (en) | Depsipeptides and their therapeutic use | |
| IL216717A0 (en) | USE OF BENZYDAMINE IN THE TREATMENT OF p40-DEPENDENT DISEASES | |
| PL2459721T3 (pl) | Udoskonalony system ekspresji ludzkiej długiej pentraksyny i jego zastosowania | |
| IL219256A0 (en) | System and method for noninvasive tissue examination | |
| GB0909894D0 (en) | Methods and preparations for curing multiple organ dysfunction in clinically ill patients | |
| GB0910048D0 (en) | Methods and preparations for curing multiple organ dysfunction in clinically ill patients | |
| GB201008106D0 (en) | Cell protective peptides for treating diseases and disorders associated with tissue damage |